cytosine has been researched along with Carcinoma, Renal Cell in 11 studies
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clear cell renal cell carcinoma (ccRCC) is highly prone to metastasize and displays an extremely low 5-year survival rate." | 1.72 | Epigenetically-regulated miR-30a/c-5p directly target TWF1 and hamper ccRCC cell aggressiveness. ( Barros-Silva, D; Carneiro, I; Correia, MP; Costa, BM; Gonçalves, CS; Henrique, R; Jerónimo, C; Lobo, J; Martins, EP; Morais, A; Moreira-Silva, F; Outeiro-Pinho, G, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Outeiro-Pinho, G | 1 |
| Barros-Silva, D | 1 |
| Moreira-Silva, F | 1 |
| Lobo, J | 1 |
| Carneiro, I | 1 |
| Morais, A | 1 |
| Martins, EP | 1 |
| Gonçalves, CS | 1 |
| Costa, BM | 1 |
| Correia, MP | 1 |
| Henrique, R | 1 |
| Jerónimo, C | 1 |
| Ramakrishnan, N | 1 |
| Bose, R | 1 |
| Artemov, AV | 1 |
| Zhigalova, N | 1 |
| Zhenilo, S | 1 |
| Mazur, AM | 1 |
| Prokhortchouk, EB | 1 |
| Chen, K | 1 |
| Zhang, J | 1 |
| Guo, Z | 1 |
| Ma, Q | 1 |
| Xu, Z | 2 |
| Zhou, Y | 1 |
| Li, Z | 1 |
| Liu, Y | 1 |
| Ye, X | 1 |
| Li, X | 1 |
| Yuan, B | 1 |
| Ke, Y | 1 |
| He, C | 1 |
| Zhou, L | 1 |
| Liu, J | 1 |
| Ci, W | 1 |
| Munari, E | 1 |
| Chaux, A | 1 |
| Vaghasia, AM | 1 |
| Taheri, D | 1 |
| Karram, S | 1 |
| Bezerra, SM | 1 |
| Gonzalez Roibon, N | 1 |
| Nelson, WG | 1 |
| Yegnasubramanian, S | 1 |
| Netto, GJ | 1 |
| Haffner, MC | 1 |
| Chacon-Camacho, OF | 1 |
| Rodriguez-Dennen, F | 1 |
| Camacho-Molina, A | 1 |
| Rasmussen, A | 1 |
| Alonso-Vilatela, E | 1 |
| Zenteno, JC | 1 |
| Townsley, CA | 1 |
| Chi, K | 1 |
| Ernst, DS | 1 |
| Belanger, K | 1 |
| Tannock, I | 1 |
| Bjarnason, GA | 1 |
| Stewart, D | 1 |
| Goel, R | 1 |
| Ruether, JD | 1 |
| Siu, LL | 1 |
| Jolivet, J | 1 |
| McIntosh, L | 1 |
| Seymour, L | 1 |
| Moore, MJ | 1 |
| Fujioka, T | 1 |
| Ishikura, K | 1 |
| Hasegawa, M | 1 |
| Ogyu, K | 1 |
| Matsushita, Y | 1 |
| Sato, M | 1 |
| Sato, F | 1 |
| Aoki, H | 1 |
| Kubo, T | 1 |
| Onishi, T | 1 |
| Machida, T | 1 |
| Akaza, H | 1 |
| Kadhim, SA | 1 |
| Bowlin, TL | 1 |
| Waud, WR | 1 |
| Angers, EG | 1 |
| Bibeau, L | 1 |
| DeMuys, JM | 1 |
| Bednarski, K | 1 |
| Cimpoia, A | 1 |
| Attardo, G | 1 |
1 review available for cytosine and Carcinoma, Renal Cell
| Article | Year |
|---|---|
[Development of new drugs for urological cancers].
Topics: Androgen Antagonists; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinoma, Renal Cell; | 1997 |
1 trial available for cytosine and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials Group.
Topics: Aged; Antineoplastic Agents; Canada; Carcinoma, Renal Cell; Cytosine; Dioxolanes; Disease Progressio | 2003 |
9 other studies available for cytosine and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Epigenetically-regulated miR-30a/c-5p directly target TWF1 and hamper ccRCC cell aggressiveness.
Topics: Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Claudin-1; Cytosine; Dec | 2022 |
Analysis of healthy and tumour DNA methylation distributions in kidney-renal-clear-cell-carcinoma using Kullback-Leibler and Jensen-Shannon distance measures.
Topics: Algorithms; Bayes Theorem; Carcinoma, Renal Cell; Computational Biology; Cytosine; Data Interpretati | 2017 |
VHL inactivation without hypoxia is sufficient to achieve genome hypermethylation.
Topics: Carcinoma, Renal Cell; Cell Line, Tumor; CRISPR-Cas Systems; Cytosine; DNA Methylation; Gene Express | 2018 |
Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer.
Topics: 5-Methylcytosine; Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Cytosine; DNA Methylation; Down- | 2016 |
Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Cytosine; DNA Methylation; | 2016 |
Clinical and molecular features of familial and sporadic cases of von Hippel-Lindau disease from Mexico.
Topics: Adult; Amino Acid Substitution; Carcinoma, Renal Cell; Central Nervous System Neoplasms; Chromosomes | 2010 |
Antitumor effects of oral administration of an interferon-inducing pyrimidinone, Bropirimine, on murine renal-cell carcinoma.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cytosine; Cytotoxicity | 1995 |
A study on direct antitumor activity of bropirimine (oral interferon inducer) for renal cell carcinoma.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cytosine; Drug Screenin | 1994 |
Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models.
Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cytosine; Dioxolanes; Drug Screening Assays, | 1997 |